Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
Rankning i aktier
#3600
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical... Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical firm that handles the entire process from research and development to the production, marketing, and distribution of diagnostic solutions for infectious diseases and various vaccines. The company operates extensively across China and in international markets. Its comprehensive product range offers diagnostic test kits for a multitude of infectious agents, including COVID-19, HIV, HTLV, Hepatitis, EV-71, and Tuberculosis. It also provides specific detection reagents for Hepatitis C and Syphilis. Beyond these, the portfolio includes advanced diagnostic tools such as automated immunoassays, ELISA kits, rapid diagnostic tests, and various chemiluminescence, clinical chemistry, and general immunodiagnostic reagents. Furthermore, Beijing Wantai is a developer and supplier of vaccines for Hepatitis E and human papillomavirus (HPV). The company serves a wide array of clients, including blood banks, hospitals and clinics, specialized reference laboratories, border inspection centers, blood-processing companies, and scientific research institutes. Established in 1991, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in China's capital city, Beijing.
Aktiekurs
$3.75
Marknadsvärde
$4.75B
Förändring (1 dag)
1.13%
Förändring (1 år)
-51.71%
Land
CN
Handel Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Kategori
Healthcare
Vinst för Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Vinst i Jun 2026 TTM: $-68.50M
Enligt de senaste finansiella rapporterna från Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. är företagets nuvarande vinst $-68.50M. År 2023 hade företaget en vinst på $196.85M, en minskning jämfört med vinsten år 2022 som var $809.33M. Vinsten som visas på denna sida är vinsten före räntor och skatt, även kallad EBIT.
Vinshistorik för Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. från 2013 till 2026
Vinst vid slutet av varje år
| År | Vinst | Ändra |
|---|---|---|
| 2026 (TTM) | $-68.50M | -840.89% |
| 2024 | $9.25M | -95.30% |
| 2023 | $196.85M | -75.68% |
| 2022 | $809.33M | 121.33% |
| 2021 | $365.67M | 212.48% |
| 2020 | $117.02M | 275.84% |
| 2019 | $31.14M | -26.22% |
| 2018 | $42.20M | 53.78% |
| 2017 | $27.44M | 24.77% |
| 2016 | $21.99M | 8.94% |
| 2015 | $20.19M | -6.87% |
| 2014 | $21.68M | 27.42% |
| 2013 | $17.01M | 0.00% |
Vinst för liknande företag eller konkurrenter
| Företag | Vinst | Skillnad i vinst | Land |
|---|---|---|---|
| $5.27B | -7,801.05% |
US
|
|
| $-3.09B | 4,406.84% |
US
|
|
| $-4.02B | 5,763.42% |
AU
|
|
| - | - |
CH
|
|
| $1.95B | -2,947.84% |
NL
|
